Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review

• by Yi-Xiao Li, Yan-Lei Hao

• June 10, 2026

This Week’s Biopharma News: Big Moves in Bispecifics

Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody

• June 9, 2026

• 5 min

POC1A promotes malignant phenotypes in non-triple-negative breast cancer cell models with EMT- and Wnt/β-catenin-related alterations

• by Jingshuang Song, Fanyu Zeng, Yong Du, Ying Huang

• June 9, 2026

Long-read sequencing for cancer liquid biopsy: advancing precision oncology

• by Grace Guzman, Analiz Rodriguez

• June 10, 2026